Adverse Event reporting information can be found in footer

Request a Meeting

HCP RESOURCES to View and Download

Firmagon CV Leavepiece

Why is it important to manage your high-risk CV patients?

Firmagon HCP Leavepiece

Learn more about Firmagon® and the MOA by downloading this leaflet

Dosing and Administration Poster

A quick reference poster with an easy-to-use guide to dosing and administering Firmagon® to your patients, starting with their initial treatment through to subsequent maintenance doses.

Reconstitution and Administration Video Including Top Tips by Leanne McCourt

Learn how to best administer a Firmagon® injection by watching our instructional video with Leanne McCourt Macmillan Urology Nurse Specialist. This quick demonstration illustrates the precise technique for administering a deep subcutaneous injection into the abdomen.Watch the video now for a comprehensive understanding of the dosing and administration process.
Leanne McCourt

Dosing and Administration Video

Firmagon is a deep subcutaneous injection administered to the abdominal region. It should be administered at a slow and steady pace over 30 seconds.

Injection sites should be varied and not be in areas where the patient will be exposed to pressure e.g. not close to waistband/ belt. Treatment should be continued after initiation and it should only be administered by a healthcare professional.

The injection site should be kept clean and patients should avoid rubbing the area. If your patient experiences a reaction at the injection site, it can be managed with paracetamol or ibuprofen or cooling methods e.g. ice packs.
Please watch this video for more information and guidance.

Mode of Action Video

Watch this video to learn more about Firmagon’s Mode of Action and the differences between antagonists and agonists.


Patient Diary

A simple guide for prostate cancer patients to help them keep a record of their treatment plan and PSA levels.

Patient Information Booklet

Coming soon.

Prostate Cancer Staging

Help your colleagues and patients understand the different prostate cancer stages, grading scores and how to interpret them.

Patient Leaflet

An easy-to-use guide for patients who have been prescribed Firmagon® that answers questions about diagnosis of hormone-dependent prostate cancer and treatment.

  1. Firmagon® 120mg injection. Summary of Product Characteristics. Ferring Pharmaceuticals Limited. October 2022. Available at: (Last Accessed March 2023)
  2. Firmagon® 80mg injection. Summary of Product Characteristics. Ferring Pharmaceuticals Limited. October 2022. Available at: (Last Accessed March 2023)

Job Code: UK-FN-2300034 - Date of preparation: November 2023


Our use of cookies

We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.

Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.